{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:35:24Z","timestamp":1772130924084,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602529, 81702324 and 81770601"],"award-info":[{"award-number":["81602529, 81702324 and 81770601"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2018206176 and H2017206141"],"award-info":[{"award-number":["H2018206176 and H2017206141"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10238-021-00698-9","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T16:02:31Z","timestamp":1615132951000},"page":"479-492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["REC8 promotes tumor migration, invasion and angiogenesis by targeting the PKA pathway in hepatocellular carcinoma"],"prefix":"10.1007","volume":"21","author":[{"given":"Jing","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-li","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-di","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-jin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5235-1457","authenticated-orcid":false,"given":"Hui-qing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,7]]},"reference":[{"key":"698_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"698_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"698_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115\u201332.","journal-title":"CA Cancer J Clin"},{"key":"698_CR4","first-page":"1","volume":"43","author":"T An","year":"2017","unstructured":"An T, Hallouch O, Chernyak V, Kamaya A, Sirlin CB. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. Abdom Radiol. 2017;43:1\u201313.","journal-title":"Abdom Radiol"},{"key":"698_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2147\/JHC.S107370","volume":"4","author":"DJ Erstad","year":"2017","unstructured":"Erstad DJ, Tanabe KK. Hepatocellular carcinoma: early-stage management challenges. J Hepatocell Carcinoma. 2017;4:81\u201392.","journal-title":"J Hepatocell Carcinoma"},{"key":"698_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2147\/JHC.S106529","volume":"4","author":"D Galun","year":"2017","unstructured":"Galun D, Srdic-Rajic T, Bogdanovic A, Loncar Z, Zuvela M. Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies. J Hepatocell Carcinoma. 2017;4:93\u2013103.","journal-title":"J Hepatocell Carcinoma"},{"key":"698_CR7","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","volume":"379","author":"A Forner","year":"2012","unstructured":"Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379:1245\u201355.","journal-title":"Lancet"},{"key":"698_CR8","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.3892\/ol.2017.6429","volume":"14","author":"Q Li","year":"2017","unstructured":"Li Q, Li S, Wu Y, Gao F. miRNA-708 functions as a tumour suppressor in hepatocellular carcinoma by targeting SMAD3. Oncol Lett. 2017;14:2552.","journal-title":"Oncol Lett"},{"key":"698_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/22774","volume":"400","author":"Y Watanabe","year":"1999","unstructured":"Watanabe Y, Nurse P. Cohesin Rec8 is required for reductional chromosome segregation at meiosis. Nature. 1999;400:461\u20134.","journal-title":"Nature"},{"key":"698_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nrc3743","volume":"14","author":"A Losada","year":"2014","unstructured":"Losada A. Cohesin in cancer: chromosome segregation and beyond. Nat Rev Cancer. 2014;14:389\u201393.","journal-title":"Nat Rev Cancer"},{"key":"698_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/2045-3701-2-5","volume":"2","author":"N Wu","year":"2012","unstructured":"Wu N, Yu H. The Smc complexes in DNA damage response. Cell Biosci. 2012;2:5.","journal-title":"Cell Biosci"},{"key":"698_CR12","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1242\/dev.090605","volume":"140","author":"S Remeseiro","year":"2013","unstructured":"Remeseiro S, Cuadrado A, Losada A. Cohesin in development and disease. Development. 2013;140:3715\u20138.","journal-title":"Development"},{"key":"698_CR13","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nature09380","volume":"467","author":"MH Kagey","year":"2010","unstructured":"Kagey MH, Newman JJ, Bilodeau S, et al. Mediator and cohesin connect gene expression and chromatin architecture. Nature. 2010;467:430\u20135.","journal-title":"Nature"},{"key":"698_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/nrm3857","volume":"15","author":"K Jeppsson","year":"2014","unstructured":"Jeppsson K, Kanno T, Shirahige K, Sjogren C. The maintenance of chromosome structure: positioning and functioning of SMC complexes. Nat Rev Mol Cell Biol. 2014;15:601\u201314.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"698_CR15","doi-asserted-by":"publisher","first-page":"9125","DOI":"10.1073\/pnas.1205074109","volume":"109","author":"K Monahan","year":"2012","unstructured":"Monahan K, Maniatis T. Role of CCCTC binding factor (CTCF) and cohesin in the generation of single-cell diversity of Protocadherin-\u0152\u00b1 gene expression. Proc Natl Acad Sci U S A. 2012;109:9125\u201330.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"698_CR16","first-page":"4","volume":"2","author":"S Alexander","year":"2013","unstructured":"Alexander S. Cohesin complexes with a potential to link mammalian meiosis to cancer. Cell Regen. 2013;2:4.","journal-title":"Cell Regen"},{"key":"698_CR17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1136\/gut.2011.241034","volume":"61","author":"Y Okamoto","year":"2012","unstructured":"Okamoto Y, Sawaki A, Ito S, et al. Aberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumour. Gut. 2012;61:392\u2013401.","journal-title":"Gut"},{"key":"698_CR18","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1016\/j.yexcr.2009.05.011","volume":"315","author":"J Erenpreisa","year":"2009","unstructured":"Erenpreisa J, Cragg MS, Salmina K, Hausmann M, Scherthan H. The role of meiotic cohesin REC8 in chromosome segregation in gamma irradiation-induced endopolyploid tumour cells. Exp Cell Res. 2009;315:2593\u2013603.","journal-title":"Exp Cell Res"},{"key":"698_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/onc.2016.187","volume":"36","author":"J Yu","year":"2016","unstructured":"Yu J, Liang Q, Wang J, et al. REC8functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype. Oncogene. 2016;36:182\u201393.","journal-title":"Oncogene"},{"key":"698_CR20","doi-asserted-by":"publisher","first-page":"39211","DOI":"10.18632\/oncotarget.5391","volume":"6","author":"D Liu","year":"2015","unstructured":"Liu D, Shen X, Zhu G, Xing M. REC8is a novel tumor suppressor gene epigenetically robustly targeted by the PI3K pathway in thyroid cancer. Oncotarget. 2015;6:39211\u201324.","journal-title":"Oncotarget"},{"issue":"1436\u201348","key":"698_CR21","first-page":"e12","volume":"145","author":"RY Wang","year":"2013","unstructured":"Wang RY, Chen L, Chen HY, et al. MUC15 inhibits dimerization of EGFR and PI3K\u2013AKT signaling and is associated with aggressive hepatocellular carcinomas in patients. Gastroenterology. 2013;145(1436\u201348):e12.","journal-title":"Gastroenterology"},{"key":"698_CR22","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3892\/ijmm.2014.1800","volume":"34","author":"W Liu","year":"2014","unstructured":"Liu W, Xu C, Wan H, et al. MicroRNA-206 overexpression promotes apoptosis, induces cell cycle arrest and inhibits the migration of human hepatocellular carcinoma HepG2 cells. Int J Mol Med. 2014;34:420\u20138.","journal-title":"Int J Mol Med"},{"key":"698_CR23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10238-019-00579-2","volume":"19","author":"L Wu","year":"2019","unstructured":"Wu L, Chen P, Ying J, et al. MAT2B mediates invasion and metastasis by regulating EGFR signaling pathway in hepatocellular carcinoma. Clin Exp Med. 2019;19:535\u201346.","journal-title":"Clin Exp Med"},{"key":"698_CR24","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/hep.29360","volume":"66","author":"H Li","year":"2017","unstructured":"Li H, Li X, Liu S, et al. Programmed cell death-1 (PD-1) checkpoint blockade in combination with a mammalian target of rapamycin inhibitor restrains hepatocellular carcinoma growth induced by hepatoma cell-intrinsic PD-1. Hepatol (Baltimore, MD). 2017;66:1920\u201333.","journal-title":"Hepatol (Baltimore, MD)"},{"key":"698_CR25","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.7150\/thno.42869","volume":"10","author":"C Zhou","year":"2020","unstructured":"Zhou C, Liu C, Liu W, et al. SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway. Theranostics. 2020;10:4627\u201343.","journal-title":"Theranostics"},{"key":"698_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13046-019-1113-3","volume":"38","author":"R Peng","year":"2019","unstructured":"Peng R, Zhang PF, Yang X, et al. Overexpression of RNF38 facilitates TGF-\u03b2 signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma. J Exp Clin Cancer Res CR. 2019;38:113.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"698_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/pmic.200390047","volume":"3","author":"A Guillot","year":"2003","unstructured":"Guillot A, Gitton C, Anglade P, Mistou MY. Proteomic analysis of Lactococcus lactis, a lactic acid bacterium. Proteomics. 2003;3:337\u201354.","journal-title":"Proteomics"},{"key":"698_CR28","doi-asserted-by":"publisher","first-page":"e26552","DOI":"10.1371\/journal.pone.0026552","volume":"6","author":"AJ McKenzie","year":"2011","unstructured":"McKenzie AJ, Campbell SL, Howe AK. Protein kinase A activity and anchoring are required for ovarian cancer cell migration and invasion. PLoS ONE. 2011;6:e26552.","journal-title":"PLoS ONE"},{"key":"698_CR29","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1073\/pnas.97.2.835","volume":"97","author":"YS Cho","year":"2000","unstructured":"Cho YS, Park YG, Lee YN, et al. Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking C\u03b1 and RII\u03b2 subunit overexpression. Proc Natl Acad Sci. 2000;97:835\u201340.","journal-title":"Proc Natl Acad Sci"},{"key":"698_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/pr.2016.36","volume":"80","author":"KM Riggle","year":"2016","unstructured":"Riggle KM, Riehle KJ, Kenerson HL, et al. Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma. Pediatr Res. 2016;80:110\u20138.","journal-title":"Pediatr Res"},{"key":"698_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/jcar.JCar_9_16","volume":"16","author":"YA Ghouri","year":"2017","unstructured":"Ghouri YA, Mian I, Rowe JH. Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis. J Carcinog. 2017;16:1.","journal-title":"J Carcinog"},{"key":"698_CR32","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.1038\/onc.2010.236","volume":"29","author":"S Whittaker","year":"2010","unstructured":"Whittaker S, Marais R, Zhu AX. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene. 2010;29:4989\u20135005.","journal-title":"Oncogene"},{"key":"698_CR33","first-page":"1583","volume":"39","author":"J Zhao","year":"2018","unstructured":"Zhao J, Geng L, Duan G, et al. REC8 inhibits EMT by downregulating EGR1 in gastric cancer cells. Oncol Rep. 2018;39:1583\u201390.","journal-title":"Oncol Rep"},{"key":"698_CR34","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/onc.2016.187","volume":"36","author":"J Yu","year":"2017","unstructured":"Yu J, Liang Q, Wang J, et al. REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype. Oncogene. 2017;36:182.","journal-title":"Oncogene"},{"key":"698_CR35","doi-asserted-by":"publisher","first-page":"39211","DOI":"10.18632\/oncotarget.5391","volume":"6","author":"D Liu","year":"2015","unstructured":"Liu D, Shen X, Zhu G, Xing M. REC8 is a novel tumor suppressor gene epigenetically robustly targeted by the PI3K pathway in thyroid cancer. Oncotarget. 2015;6:39211.","journal-title":"Oncotarget"},{"key":"698_CR36","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/nm.3391","volume":"19","author":"L Wan","year":"2013","unstructured":"Wan L, Pantel K, Kang Y. Tumor metastasis: moving new biological insights into the clinic. Nat Med. 2013;19:1450.","journal-title":"Nat Med"},{"key":"698_CR37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.molcel.2006.09.006","volume":"24","author":"MG Gold","year":"2006","unstructured":"Gold MG, Lygren B, Dokurno P, et al. Molecular basis of AKAP specificity for PKA regulatory subunits. Mol Cell. 2006;24:383\u201395.","journal-title":"Mol Cell"},{"key":"698_CR38","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/jcb.25798","volume":"118","author":"M Massimi","year":"2017","unstructured":"Massimi M, Cardarelli S, Galli F, et al. Increase of intracellular cyclic AMP by PDE4 inhibitors affects HepG2 cell cycle progression and survival. J Cell Biochem. 2017;118:1401\u201311.","journal-title":"J Cell Biochem"},{"key":"698_CR39","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3390\/cells8121511","volume":"8","author":"M Massimi","year":"2019","unstructured":"Massimi M, Ragusa F, Cardarelli S, Giorgi M. Targeting cyclic AMP signalling in hepatocellular carcinoma. Cells. 2019;8:1511.","journal-title":"Cells"},{"key":"698_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.bbamcr.2004.03.005","volume":"1692","author":"AK Howe","year":"2004","unstructured":"Howe AK. Regulation of actin-based cell migration by cAMP\/PKA. Biochim Biophys Acta. 2004;1692:159\u201374.","journal-title":"Biochim Biophys Acta"},{"key":"698_CR41","doi-asserted-by":"publisher","first-page":"112200","DOI":"10.1016\/j.jphotochem.2019.112200","volume":"388","author":"Q Weng","year":"2020","unstructured":"Weng Q, Zheng X, Zhang S, et al. A photoelectrochemical immunosensor based on natural pigment sensitized ZnO for alpha-fetoprotein detection. J Photochem Photobiol A Chem. 2020;388:112200.","journal-title":"J Photochem Photobiol A Chem"},{"key":"698_CR42","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1200\/JCO.2019.37.4_suppl.346","volume":"37","author":"AG Bocobo","year":"2019","unstructured":"Bocobo AG, Bracci PM, Parks A, et al. Changes in alpha-fetoprotein (AFP) and systemic therapy outcomes in advanced hepatocellular carcinoma (HCC): a multicenter retrospective analysis. J Clin Oncol. 2019;37:346.","journal-title":"J Clin Oncol"},{"key":"698_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10238-018-0537-y","volume":"19","author":"NM Abdel-Hamid","year":"2019","unstructured":"Abdel-Hamid NM, Abdullah AH. Serum histamine and acetylcholine variations as new noninvasive biochemical markers in staging of experimental hepatocellular carcinoma. Clin Exp Med. 2019;19:115\u201320.","journal-title":"Clin Exp Med"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-021-00698-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-021-00698-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-021-00698-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T21:10:55Z","timestamp":1675026655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-021-00698-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,7]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["698"],"URL":"https:\/\/doi.org\/10.1007\/s10238-021-00698-9","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,7]]},"assertion":[{"value":"27 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All patients signed their informed consent. The study was approved by the Ethics Committee of Clinical Research of the second Hospital of Hebei Medical University. All patients gave the written informed consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants in this study were informed and gave a written consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}